← Evidence map

ReviewTheranostics2026

Future opportunities and nuances with the use of PSMA PET in prostate cancer (MD PET 1).

Alicia K Morgans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42094603